These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 15383574)

  • 21. Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells.
    Verhasselt V; Vosters O; Beuneu C; Nicaise C; Stordeur P; Goldman M
    Eur J Immunol; 2004 Mar; 34(3):762-772. PubMed ID: 14991606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
    Koenen HJ; Fasse E; Joosten I
    J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.
    LaRosa DF; Gelman AE; Rahman AH; Zhang J; Turka LA; Walsh PT
    Immunol Lett; 2007 Feb; 108(2):183-8. PubMed ID: 17270282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming.
    Ogata M; Ito T; Shimamoto K; Nakanishi T; Satsutani N; Miyamoto R; Nomura S
    Int Immunol; 2013 Mar; 25(3):171-82. PubMed ID: 23125331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
    Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
    J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.
    Cavani A; Nasorri F; Ottaviani C; Sebastiani S; De Pità O; Girolomoni G
    J Immunol; 2003 Dec; 171(11):5760-8. PubMed ID: 14634084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive oligodeoxynucleotides induced tolerogenic plasmacytoid dendritic cells and ameliorated the experimental autoimmune neuritis.
    Wang YZ; Lv H; Hao YL; Zhang HQ; Li L; Cai GM; Hu M; Jia CX; Feng XG; Kong QX
    Immunol Lett; 2015 Jul; 166(1):13-8. PubMed ID: 25952624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.
    Zheng SG; Gray JD; Ohtsuka K; Yamagiwa S; Horwitz DA
    J Immunol; 2002 Oct; 169(8):4183-9. PubMed ID: 12370347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
    Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
    Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of adipose-derived stem cells and non-methylated CpG-oligodeoxynucleotides on peripheral blood CD4
    Chen XL; Zheng CZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):590-595. PubMed ID: 28506355
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Lawless OJ; Bellanti JA; Brown ML; Sandberg K; Umans JG; Zhou L; Chen W; Wang J; Wang K; Zheng SG
    Allergy Asthma Proc; 2018 Mar; 39(2):143-152. PubMed ID: 29490770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
    Warren TL; Bhatia SK; Acosta AM; Dahle CE; Ratliff TL; Krieg AM; Weiner GJ
    J Immunol; 2000 Dec; 165(11):6244-51. PubMed ID: 11086059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells.
    Verginis P; Li HS; Carayanniotis G
    J Immunol; 2005 Jun; 174(11):7433-9. PubMed ID: 15905592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM; Parihar R; Carson WE
    J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate Toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T cells.
    Schirmbeck R; Riedl P; Zurbriggen R; Akira S; Reimann J
    J Immunol; 2003 Nov; 171(10):5198-207. PubMed ID: 14607920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R; Lenert P
    J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.
    Romagnani C; Della Chiesa M; Kohler S; Moewes B; Radbruch A; Moretta L; Moretta A; Thiel A
    Eur J Immunol; 2005 Aug; 35(8):2452-8. PubMed ID: 15997468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.